PNC Financial Services Group Inc. lifted its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 37.0% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 18,608 shares of the medical instruments supplier’s stock after purchasing an additional 5,023 shares during the quarter. PNC Financial Services Group Inc.’s holdings in DENTSPLY SIRONA were worth $692,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of XRAY. Skandinaviska Enskilda Banken AB publ boosted its holdings in DENTSPLY SIRONA by 5.1% in the third quarter. Skandinaviska Enskilda Banken AB publ now owns 35,062 shares of the medical instruments supplier’s stock valued at $1,323,000 after acquiring an additional 1,700 shares in the last quarter. ING Groep NV bought a new stake in shares of DENTSPLY SIRONA during the 3rd quarter valued at $1,398,000. SG Americas Securities LLC boosted its holdings in shares of DENTSPLY SIRONA by 459.2% during the 3rd quarter. SG Americas Securities LLC now owns 116,189 shares of the medical instruments supplier’s stock valued at $4,385,000 after buying an additional 95,413 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its holdings in shares of DENTSPLY SIRONA by 2.0% during the 3rd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 723,617 shares of the medical instruments supplier’s stock valued at $27,309,000 after buying an additional 14,477 shares in the last quarter. Finally, Norinchukin Bank The boosted its holdings in shares of DENTSPLY SIRONA by 11.0% during the 3rd quarter. Norinchukin Bank The now owns 28,598 shares of the medical instruments supplier’s stock valued at $1,079,000 after buying an additional 2,829 shares in the last quarter. Institutional investors and hedge funds own 99.18% of the company’s stock.

XRAY opened at $49.09 on Friday. The company has a quick ratio of 1.27, a current ratio of 1.86 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $10.92 billion, a PE ratio of 24.42, a P/E/G ratio of 2.56 and a beta of 1.08. DENTSPLY SIRONA Inc has a 1 year low of $33.93 and a 1 year high of $57.44.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, March 1st. The medical instruments supplier reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.54 by $0.04. The firm had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.02 billion. DENTSPLY SIRONA had a positive return on equity of 8.21% and a negative net margin of 25.36%. DENTSPLY SIRONA’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.82 EPS. Sell-side analysts forecast that DENTSPLY SIRONA Inc will post 2.31 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, April 12th. Stockholders of record on Friday, March 29th will be given a $0.087 dividend. This represents a $0.35 annualized dividend and a dividend yield of 0.71%. The ex-dividend date of this dividend is Thursday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is presently 17.41%.

A number of brokerages have recently commented on XRAY. UBS Group boosted their target price on shares of DENTSPLY SIRONA from $42.00 to $53.00 and gave the company a “neutral” rating in a report on Tuesday, March 12th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a report on Saturday, March 9th. William Blair upgraded shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating in a report on Friday, March 1st. Robert W. Baird boosted their target price on shares of DENTSPLY SIRONA from $42.00 to $50.00 and gave the company a “neutral” rating in a report on Monday, March 4th. Finally, HC Wainwright restated a “neutral” rating and set a $49.00 target price (up previously from $40.00) on shares of DENTSPLY SIRONA in a report on Monday, March 4th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and seven have issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $51.33.

COPYRIGHT VIOLATION WARNING: This report was originally published by Watch List News and is the property of of Watch List News. If you are viewing this report on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this report can be viewed at https://www.watchlistnews.com/pnc-financial-services-group-inc-has-692000-stake-in-dentsply-sirona-inc-xray/2897290.html.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: Sell-Side Analysts

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.